Daymark Health Secures $20M to Redefine Cancer Care
September 29, 2025, 9:33 am
Daymark Health secured $20M in Series A funding. Healthier Capital and Blue Venture Fund led the round. This investment scales Daymark's value-based cancer care platform. The company revolutionizes cancer treatment, offering integrated support. It addresses clinical, social, and mental health needs. Support comes via virtual and in-home services. Daymark partners with oncologists, primary care, and health plans. The tech-enabled model provides 24/7 care navigation, symptom management, and mental health assistance. This funding drives national expansion. It brings innovative technology to more patients. The move signals a major shift in oncology. Payers and providers embrace patient-first, comprehensive solutions. Daymark champions intelligent, frictionless cancer care. This advances healthcare delivery across the nation, improving outcomes and managing costs effectively.
Daymark Health makes a significant impact. The company announced a $20 million Series A funding round. This substantial investment powers its mission. It redefines the cancer care experience. Healthier Capital and Blue Venture Fund spearheaded this financing. Existing investors also reaffirmed their commitment. Yosemite, Maverick Ventures, and Oncology Ventures participated again. This capital infusion ensures Daymark's continued growth. It expands access to critical, comprehensive cancer support. The healthcare landscape is evolving rapidly. Daymark stands at the forefront of this transformation.
Daymark Health's core mission centers on patients. It aims to transform the cancer journey. The company offers a uniquely integrated care model. This approach moves beyond traditional clinical treatment. It addresses a patient's full spectrum of needs. Clinical, social, and mental health are all prioritized. This holistic support ensures better overall well-being. It empowers individuals facing cancer. Daymark’s commitment to patient-first care reshapes oncology.
Care delivery at Daymark is both innovative and accessible. The company leverages a hybrid model. Virtual support connects patients remotely. In-home services provide direct, personal attention. This flexibility meets diverse patient needs. Daymark also fosters strong collaboration. It works hand-in-hand with oncologists. Primary care providers are integral partners. A sophisticated, tech-enabled platform streamlines operations. This digital infrastructure enhances efficiency. A dedicated team of community-based clinicians complements the technology. They extend compassionate care directly to patients.
Daymark provides a suite of essential services. These offerings are crucial for cancer patients. Expert care navigation guides individuals through complex systems. Patients receive continuous 24/7 support. This ensures help is always available. Mental health assistance offers vital emotional support. Effective symptom management improves daily life quality. Crucial social support addresses broader determinants of health. These services build a robust support network. They empower patients throughout their treatment.
Strategic partnerships define Daymark’s expansion. The company actively collaborates with health plans. These alliances align incentives across the healthcare ecosystem. They aim to improve patient outcomes. Simultaneously, they manage the overall cost of care. This value-based approach benefits all stakeholders. Payers face increasing pressures managing specialty risk. Providers seek efficient, patient-centric solutions. Daymark's model directly addresses these evolving market demands. It builds a more sustainable healthcare future.
The $20 million funding fuels ambitious expansion plans. Daymark will significantly scale its cancer care platform. It plans to forge new partnerships. These will include health plans and providers across the United States. The goal is to bring innovative technology to more patients. Daymark's comprehensive care model will reach underserved communities. This national expansion solidifies its leadership position. It ensures broader access to groundbreaking oncology solutions. Many more patients will benefit from this growth.
Leading investors show strong confidence in Daymark. Healthier Capital is known for backing tech-driven innovators. Their focus is on delivering healthier outcomes for everyone. Blue Venture Fund represents a powerful collaboration. It unites various Blue Cross and Blue Shield companies. The Blue Cross Blue Shield Association and Sandbox are also key contributors. This group has collectively committed over $1.2 billion across five funds. These substantial investments underscore a clear industry trend. Oncology is undergoing a rapid, significant transformation. Integrated, sustainable care models are now deemed essential. Daymark is perfectly positioned at this pivotal moment.
Daymark Health also strengthens its leadership. The company welcomes new board members. Dr. Aman Mahajan from Healthier Capital joins the board. Kelsey Maguire from Blue Venture Fund also takes a seat. These additions bring invaluable expertise. Their strategic insights will guide Daymark’s future direction. This reinforces the company's commitment to innovation. It enhances its ability to navigate complex healthcare challenges. Strong leadership underpins Daymark's ambitious vision.
Daymark champions value-based cancer care. This approach prioritizes patient well-being and outcomes. It moves away from fee-for-service models. The goal is to improve health while controlling costs. Personalized care becomes scalable and accessible. Daymark actively breaks down healthcare delivery silos. It ensures a seamless, coordinated patient experience. The focus remains on empowering patients. This sets a new industry standard for oncology treatment. Daymark shapes the future of cancer care delivery.
Daymark Health leads the way in healthcare innovation. Its $20 million funding round confirms market belief. The integrated platform offers groundbreaking support. It addresses patients' needs holistically. This significantly advances cancer care across the U.S. Daymark builds a healthier, more compassionate future. It brings intelligent and frictionless care to many. The profound impact will resonate widely.
Daymark Health makes a significant impact. The company announced a $20 million Series A funding round. This substantial investment powers its mission. It redefines the cancer care experience. Healthier Capital and Blue Venture Fund spearheaded this financing. Existing investors also reaffirmed their commitment. Yosemite, Maverick Ventures, and Oncology Ventures participated again. This capital infusion ensures Daymark's continued growth. It expands access to critical, comprehensive cancer support. The healthcare landscape is evolving rapidly. Daymark stands at the forefront of this transformation.
Daymark Health's core mission centers on patients. It aims to transform the cancer journey. The company offers a uniquely integrated care model. This approach moves beyond traditional clinical treatment. It addresses a patient's full spectrum of needs. Clinical, social, and mental health are all prioritized. This holistic support ensures better overall well-being. It empowers individuals facing cancer. Daymark’s commitment to patient-first care reshapes oncology.
Care delivery at Daymark is both innovative and accessible. The company leverages a hybrid model. Virtual support connects patients remotely. In-home services provide direct, personal attention. This flexibility meets diverse patient needs. Daymark also fosters strong collaboration. It works hand-in-hand with oncologists. Primary care providers are integral partners. A sophisticated, tech-enabled platform streamlines operations. This digital infrastructure enhances efficiency. A dedicated team of community-based clinicians complements the technology. They extend compassionate care directly to patients.
Daymark provides a suite of essential services. These offerings are crucial for cancer patients. Expert care navigation guides individuals through complex systems. Patients receive continuous 24/7 support. This ensures help is always available. Mental health assistance offers vital emotional support. Effective symptom management improves daily life quality. Crucial social support addresses broader determinants of health. These services build a robust support network. They empower patients throughout their treatment.
Strategic partnerships define Daymark’s expansion. The company actively collaborates with health plans. These alliances align incentives across the healthcare ecosystem. They aim to improve patient outcomes. Simultaneously, they manage the overall cost of care. This value-based approach benefits all stakeholders. Payers face increasing pressures managing specialty risk. Providers seek efficient, patient-centric solutions. Daymark's model directly addresses these evolving market demands. It builds a more sustainable healthcare future.
The $20 million funding fuels ambitious expansion plans. Daymark will significantly scale its cancer care platform. It plans to forge new partnerships. These will include health plans and providers across the United States. The goal is to bring innovative technology to more patients. Daymark's comprehensive care model will reach underserved communities. This national expansion solidifies its leadership position. It ensures broader access to groundbreaking oncology solutions. Many more patients will benefit from this growth.
Leading investors show strong confidence in Daymark. Healthier Capital is known for backing tech-driven innovators. Their focus is on delivering healthier outcomes for everyone. Blue Venture Fund represents a powerful collaboration. It unites various Blue Cross and Blue Shield companies. The Blue Cross Blue Shield Association and Sandbox are also key contributors. This group has collectively committed over $1.2 billion across five funds. These substantial investments underscore a clear industry trend. Oncology is undergoing a rapid, significant transformation. Integrated, sustainable care models are now deemed essential. Daymark is perfectly positioned at this pivotal moment.
Daymark Health also strengthens its leadership. The company welcomes new board members. Dr. Aman Mahajan from Healthier Capital joins the board. Kelsey Maguire from Blue Venture Fund also takes a seat. These additions bring invaluable expertise. Their strategic insights will guide Daymark’s future direction. This reinforces the company's commitment to innovation. It enhances its ability to navigate complex healthcare challenges. Strong leadership underpins Daymark's ambitious vision.
Daymark champions value-based cancer care. This approach prioritizes patient well-being and outcomes. It moves away from fee-for-service models. The goal is to improve health while controlling costs. Personalized care becomes scalable and accessible. Daymark actively breaks down healthcare delivery silos. It ensures a seamless, coordinated patient experience. The focus remains on empowering patients. This sets a new industry standard for oncology treatment. Daymark shapes the future of cancer care delivery.
Daymark Health leads the way in healthcare innovation. Its $20 million funding round confirms market belief. The integrated platform offers groundbreaking support. It addresses patients' needs holistically. This significantly advances cancer care across the U.S. Daymark builds a healthier, more compassionate future. It brings intelligent and frictionless care to many. The profound impact will resonate widely.